SUSANNA ELIZABETH PITRUZZELLO
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family MOBILE, AL NPI 1811293087
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family AL NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$3,210.70
- Category: General Payments
- Program years: PY2020–2024
- Record count: 180
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $859.19 across 47 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $842.17 | 46 |
| Education | $17.02 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $129.52 | 7 |
| Celgene Corporation | $100.12 | 4 |
| E.R. Squibb & Sons, L.L.C. | $87.28 | 5 |
| Merck Sharp & Dohme Corporation | $70.49 | 3 |
| Exelixis Inc. | $69.67 | 4 |
| Janssen Biotech, Inc. | $64.12 | 4 |
| Acerta Pharma LLC | $53.44 | 3 |
| EISAI INC. | $50.37 | 3 |
| Regeneron Healthcare Solutions, Inc. | $36.12 | 2 |
| BeiGene USA, Inc. | $28.27 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.54 | 1 |
| Ipsen Biopharmaceuticals, Inc | $21.23 | 1 |
| GENZYME CORPORATION | $18.43 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $17.87 | 1 |
| Incyte Corporation | $15.78 | 1 |
| Mirati Therapeutics, Inc. | $15.75 | 1 |
| Deciphera Pharmaceuticals Inc. | $14.79 | 1 |
| SERVIER PHARMACEUTICALS LLC | $14.32 | 1 |
| TAIHO ONCOLOGY, INC. | $14.05 | 1 |
| Daiichi Sankyo Inc. | $14.03 | 1 |
By program year
Records — PY2024 (47)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.